{
  "retracted": false,
  "timestamp": 1525737600000,
  "updates": [
    {
      "timestamp": 1585553722066,
      "identifier": {
        "doi": "10.1182/bloodadvances.2018019745"
      },
      "type": "erratum"
    }
  ],
  "identifier": {
    "doi": "10.1182/bloodadvances.2017014126"
  },
  "publisher": "American Society of Hematology",
  "title": "Fanciullino R, Farnault L, Donnette M, et al. CDA as a predictive marker for life-threatening toxicities in patients with AML treated with cytarabine. Blood Adv. 2018;2(5):462-469."
}
